Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia

Respiratory Failure Clinical Trial

— O2MATIC-ACUT  

Official title:

Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04079465
• Other study ID #: O2MATIC-ACUTE
• Status: Recruiting
• Phase: N/A
• Start date: October 1, 2019
• Est. completion date: December 31, 2024

Study information

• Verified date: October 2023
• Source: Hvidovre University Hospital
• Contact: Ejvind Frausing Hansen, MD
• Phone: +45 3862 3233
• Email: ejvind.frausing.hansen[@]regionh.dk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to examine if automated oxygen delivery with O2matic allows for faster weaning from oxygen supply and better oxygen control than manually controlled oxygen therapy for patients admitted to the emergency department with acute hypoxemia. Furthermore it will be tested if O2matic compared to manual control allows for earlier discharge.

Description:

Closed-loop control of oxygen therapy is described in the literature used for preterm infants, trauma patients, medical emergency use, and for patients with Chronic Obstructive Pulmonary Disease (COPD). O2matic is a closed-loop system that is based on continuous and non-invasive measurement of pulse rate and oxygen-saturation (SpO2). The algorithm in O2matic controls oxygen delivery with the aim of keeping the SpO2 within the desired interval, which could be 88-92 % for patients at risk of hypercapnia or 94-98 % for patients with pneumonia, asthma exacerbation, heart failure and other medical emergencies, according to guidelines from British Thoracic Society (BTS). SpO2-interval can be set for the individual patients, as can the range of acceptable oxygen-flow. If SpO2 or oxygen-flow cannot be maintained within the desired intervals an alarm will sound.

All studies on closed-loop systems have shown that this method is better than manually control by nurse to maintain saturation within the desired interval. Furthermore, some studies have indicated that closed-loop has the possibility to reduce admission time and to reduce time spent with oxygen therapy, due to more efficient and faster withdrawal from oxygen supplementation.

In the present study O2matic will be tested versus manual control, for patients admitted to the emergency department with acute hypoxemia due to any reason, except for carbon monoxide (CO) poisoning and other conditions where SpO2 is not a reliable measure of hypoxemia. During the study the patients will either have oxygen controlled with O2matic or manually by nursing staff for 24 hours or until discharge or weaning from oxygen supply. All patients will have continuous logging of pulse rate, oxygen-saturation and oxygen-flow with O2matic, but only in the O2matic active group, the algorithm will control oxygen-delivery.

The primary hypothesis is that O2matic compared to manual control allows for faster weaning from oxygen supplementation, and that more patients will be weaned from oxygen supplementation within a time frame of 24 hours. Furthermore it will be tested if O2matic compared to manual control allows for earlier hospital discharge. It will be tested if O2matic is better than manual control in maintaining oxygen-saturation within the desired interval and reducing time with unintended hypoxia and hyperoxia.

No safety issues has been reported in the literature. O2matic is approved in Europe with "Conformité Européenne" (CE) mark, and approved for clinical testing by The Danish Medicines Agency, The Ethics Committee in the Capital Region of Denmark and by the regional Data Protection Board. The study will be conducted according to Good Clinical Practice (GCP) standards with independent monitoring. All adverse events and serious adverse events will be monitored and serious adverse events will be reported to Danish Medicines Agency.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Admission with hypoxemic respiratory failure

• Age >= 18 years

• Expected duration of admission > 24 hours

• Need for oxygen supplementation to maintain SpO2 >= 88 % (patients at risk of hypercapnia) or SpO2 >= 94 % (other patients)

• Cognitively able to participate in the study

• Willing to participate and give informed consent

Exclusion Criteria:

• Need or anticipated need for mechanical ventilation (intermittent Continuous Positive Airway Pressure (CPAP) is allowed)

• Patients with CO-poisoning or other condition with unreliable SpO2.

• Patients in need of oxygen supplementation at more than 10 liters/min

• Pregnancy

• Cognitive or language barriers for participation

Related Conditions & MeSH terms

• Hypoxemia
• Hypoxemic Respiratory Failure
• Hypoxia
• Respiratory Failure
• Respiratory Insufficiency

Intervention

Device:
• O2matic
O2matic controls oxygen supply with a closed-loop feedback from a pulse oximeter. The aim is to maintain SpO2 within a predefined target interval according to guidelines for the specific condition causing hypoxemia, with the lowest possible supplementation of oxygen.

Locations

Country	Name	City	State
Denmark	Amager Hospital	Copenhagen
Denmark	Hvidovre Hospital	Hvidovre

Sponsors (2)

Lead Sponsor	Collaborator
Hvidovre University Hospital	Innovation Fund Denmark

Country where clinical trial is conducted

Denmark, 

References & Publications (4)

Chu DK, Kim LH, Young PJ, Zamiri N, Almenawer SA, Jaeschke R, Szczeklik W, Schunemann HJ, Neary JD, Alhazzani W. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018 Apr 28;391(10131):1693-1705. doi: 10.1016/S0140-6736(18)30479-3. Epub 2018 Apr 26. — View Citation

Cornet AD, Kooter AJ, Peters MJ, Smulders YM. The potential harm of oxygen therapy in medical emergencies. Crit Care. 2013 Apr 18;17(2):313. doi: 10.1186/cc12554. — View Citation

Hansen EF, Hove JD, Bech CS, Jensen JS, Kallemose T, Vestbo J. Automated oxygen control with O2matic(R) during admission with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018 Dec 14;13:3997-4003. doi: 10.2147/COPD.S183762. eCollection 2018. — View Citation

O'Driscoll BR, Howard LS, Earis J, Mak V. British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017 May 15;4(1):e000170. doi: 10.1136/bmjresp-2016-000170. eCollection 2017. No abstract available. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Probability of weaning from oxygen within 24 hours	Fraction of patients weaned from oxygen supplementation within 24 hours	24 hours
Secondary	Probability of weaning from oxygen within 12 hours	Fraction of patients weaned from oxygen supplementation within 12 hours	12 hours
Secondary	Duration of admission	Time from admission to emergency department to discharge from hospital	30 days
Secondary	Time within SpO2 target interval	Fraction of time within prescribed SpO2 interval in O2matic and manual arm	24 hours
Secondary	Time with minor hypoxemia	Fraction of time with SpO2 at 1 to 3 percentage points below target interval	24 hours
Secondary	Time with severe hypoxemia	Fraction of time with SpO2 at 4 or more percentage points below target interval	24 hours
Secondary	Time with hyperoxia	Fraction of time with SpO2 above target interval in O2matic and manual arm	24 hours